학술논문
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Document Type
Article
Author
Eron, Joseph J; Young, Benjamin; Cooper, David A; Youle, Michael; DeJesus, Edwin; Andrade-Villanueva, Jaime; Workman, Cassy; Zajdenverg, Roberto; Fätkenheuer, Gerd; Berger, Daniel S; Kumar, Princy N; Rodgers, Anthony J; Shaughnessy, Melissa A; Walker, Monica L; Barnard, Richard JO; Miller, Michael D; DiNubile, Mark J; Nguyen, Bach-Yen; Leavitt, Randi; Xu, Xia; Sklar, Peter
Source
In The Lancet 2010 375(9712):396-407
Subject
Language
ISSN
0140-6736